ArticleAnnals of medicine2025

Response to letter regarding 'Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis'.

Huibin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.